Rabinder Buttar

Dr Buttar received numerous business awards in 2010, including the Ernst & Young ‘Scottish Entrepreneur of the Year’ and the Institute of Directors’ ‘Director of the Year for Glasgow & West of Scotland’.

During 2010, Dr Buttar was awarded an Honorary Doctorate by the University of West of Scotland for her 20 years contribution to life sciences. In 2009, Dr Buttar was named by Real Business as one of Britain’s 100 Most Entrepreneurial Women and was officially congratulated by the Scottish Parliament for contributing to the Scottish economy and building clinical research teams across the globe.

Dr Buttar’s clinical research experience spans more than two decades within major pharmaceutical companies and currently her own organisation, ClinTec. Dr Buttar has transformed ClinTec since its inception in 1997 into a universally respected clinical research organisation with a strong presence in emerging markets and global coverage of over 40 countries across 5 continents. ClinTec has received numerous recognitions, including the Queen’s Award for Enterprise, awarded in April 2011. In 2010, ClinTec was ranked by Deloitte as number 27 of the top 100 fastest growing
privately owned technology companies in Britain and number 226 out of the top 500 in Europe, the Middle East and Africa.

Having previously obtained a BSc degree in Biochemistry from Glasgow University, Dr Buttar then graduated with a PhD in Immunology in 1988 from the University of Strathclyde in Scotland. She served for four years on the board of the Institute of Clinical Research (ICR UK), a key organisation in the UK for the education of clinical research professionals. Dr Buttar is an Honorary Fellow of ICR UK, a Fellow of the Royal Society of Medicine and a graduate in Management Studies from Reading University. Dr Buttar currently serves on the editorial advisory board of Scrip Clinical Research and the Journal of Clinical Studies.